CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Pegasus Mercantile Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Pegasus Mercantile Inc
1100 - 1111 Melville St
Phone: (604) 484-0355p:604 484-0355 VANCOUVER, BC  V6E 3V6  Canada Ticker: LOANLOAN
Business Summary
Pegasus Mercantile Inc. is a Canada-based prospect generator that provides companies with technology, financial, operational, and management assistance in the market for global wellness products and novel consumer goods and services. The Company is focused on hemp, cannabidiol (CBD), related, functional mushrooms, psilocybin plus other psychedelics, helping companies create sustainable products that elevate their personal health and wellbeing. It is focused on the specific areas of pain, depression and mental illness. By investing in pioneering techniques, such as micro-dosing using organic compounds and synthetic molecules. It is transforming the treatment of chronic pain, psychiatric ailments and depression by pioneering trials of fixed-dose drugs, combining psilocybin, ketamine, and MDMA, embracing the endless possibilities of micro-dosing. It has 100% interest in Shanti Therapeutics Pty Ltd. (Shanti), which is focused on psychedelic MDMA-based drug development research.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20259/30/2024Yes----

Industries
SIC Code Description
6799 Investors, not elsewhere classified
8742 Management consulting services

Business Names
Business Name
GWS
LOAN
O3X
XTCY

General Information
Outstanding Shares: 11,631,411 (As of 5/27/2025)
Stock Exchange: CNQ
Fax Number: (604) 484-8989


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, June 5, 2025